These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25827401)

  • 1. New paradigm of an old target: an update on structural biology and current progress in drug design towards plasmepsin II.
    Dan N; Bhakat S
    Eur J Med Chem; 2015 May; 95():324-48. PubMed ID: 25827401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmepsins as potential targets for new antimalarial therapy.
    Ersmark K; Samuelsson B; Hallberg A
    Med Res Rev; 2006 Sep; 26(5):626-66. PubMed ID: 16838300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fighting malaria: structure-guided discovery of nonpeptidomimetic plasmepsin inhibitors.
    Huizing AP; Mondal M; Hirsch AK
    J Med Chem; 2015 Jul; 58(13):5151-63. PubMed ID: 25719272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimalarials: Review of Plasmepsins as Drug Targets and HIV Protease Inhibitors Interactions.
    Miller Iii WA; Teye J; Achieng AO; Mogire RM; Akala H; Ong'echa JM; Rathi B; Durvasula R; Kempaiah P; Kwofie SK
    Curr Top Med Chem; 2019; 18(23):2022-2028. PubMed ID: 30499404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary flavonoids fisetin and myricetin: dual inhibitors of Plasmodium falciparum falcipain-2 and plasmepsin II.
    Jin H; Xu Z; Cui K; Zhang T; Lu W; Huang J
    Fitoterapia; 2014 Apr; 94():55-61. PubMed ID: 24468190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmepsin Inhibitors in Antimalarial Drug Discovery: Medicinal Chemistry and Target Validation (2000 to Present).
    Cheuka PM; Dziwornu G; Okombo J; Chibale K
    J Med Chem; 2020 May; 63(9):4445-4467. PubMed ID: 31913032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.
    Qidwai T; Yadav DK; Khan F; Dhawan S; Bhakuni RS
    Curr Pharm Des; 2012; 18(37):6133-54. PubMed ID: 22670592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight into selectivity of peptidomimetic inhibitors with modified statine core for plasmepsin II of Plasmodium falciparum over human cathepsin D.
    Dali B; Keita M; Megnassan E; Frecer V; Miertus S
    Chem Biol Drug Des; 2012 Apr; 79(4):411-30. PubMed ID: 22129033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin.
    Hidaka K; Kimura T; Ruben AJ; Uemura T; Kamiya M; Kiso A; Okamoto T; Tsuchiya Y; Hayashi Y; Freire E; Kiso Y
    Bioorg Med Chem; 2008 Dec; 16(23):10049-60. PubMed ID: 18952439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computer-aided design and synthesis of nonpeptidic plasmepsin II and IV inhibitors.
    Luksch T; Chan NS; Brass S; Sotriffer CA; Klebe G; Diederich WE
    ChemMedChem; 2008 Sep; 3(9):1323-36. PubMed ID: 18752222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malaria parasite plasmepsins: More than just plain old degradative pepsins.
    Nasamu AS; Polino AJ; Istvan ES; Goldberg DE
    J Biol Chem; 2020 Jun; 295(25):8425-8441. PubMed ID: 32366462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azole-based non-peptidomimetic plasmepsin inhibitors.
    Kinena L; Leitis G; Kanepe-Lapsa I; Bobrovs R; Jaudzems K; Ozola V; Suna E; Jirgensons A
    Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800151. PubMed ID: 30063266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region.
    Gambini L; Rizzi L; Pedretti A; Taglialatela-Scafati O; Carucci M; Pancotti A; Galli C; Read M; Giurisato E; Romeo S; Russo I
    PLoS One; 2015; 10(11):e0142509. PubMed ID: 26566224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flap flexibility amongst plasmepsins I, II, III, IV, and V: Sequence, structural, and molecular dynamics analyses.
    McGillewie L; Soliman ME
    Proteins; 2015 Sep; 83(9):1693-705. PubMed ID: 26146842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plerixafor and related macrocyclic amines are potential drug candidates in treatment of malaria by "filling the flap" region of plasmepsin enzymes.
    Abiri A
    Med Hypotheses; 2018 Sep; 118():68-73. PubMed ID: 30037618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism-based inhibitors of the aspartyl protease plasmepsin II as potential antimalarial agents.
    Gupta D; Yedidi RS; Varghese S; Kovari LC; Woster PM
    J Med Chem; 2010 May; 53(10):4234-47. PubMed ID: 20438064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of both plasmepsin inhibitory activity and antimalarial activity by 2-aminoethylamino substitution.
    Miura T; Hidaka K; Uemura T; Kashimoto K; Hori Y; Kawasaki Y; Ruben AJ; Freire E; Kimura T; Kiso Y
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4836-9. PubMed ID: 20634066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrrolidine derivatives as plasmepsin inhibitors: binding mode analysis assisted by molecular dynamics simulations of a highly flexible protein.
    Luksch T; Blum A; Klee N; Diederich WE; Sotriffer CA; Klebe G
    ChemMedChem; 2010 Mar; 5(3):443-54. PubMed ID: 20112327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid.
    Kasam V; Zimmermann M; Maass A; Schwichtenberg H; Wolf A; Jacq N; Breton V; Hofmann-Apitius M
    J Chem Inf Model; 2007; 47(5):1818-28. PubMed ID: 17727268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of potent inhibitors of the malaria aspartyl proteases plasmepsin I and II. Use of solid-phase synthesis to explore novel statine motifs.
    Johansson PO; Chen Y; Belfrage AK; Blackman MJ; Kvarnström I; Jansson K; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B
    J Med Chem; 2004 Jun; 47(13):3353-66. PubMed ID: 15189032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.